Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Ignacio Gómez-CenturiónGillen OarbeascoaMaría Carmen GarcíaMaría Carmen López FresneñaMaría Josefa Martínez CarreñoVicente Escudero VilaplanaEva González-HabaRebeca BailénNieves DoradoLuis Miguel JuárezGabriela Rodríguez MacíasPatricia Font LópezCristina EncinasMariana Bastos-OreiroJavier AnguitaMaría SanjurjoJosé Luis Díez-MartinMi KwonPublished in: International journal of hematology (2021)
Implementation of a Hematology HAH unit was feasible and safe, and provided thorough advanced care to a high-risk population. Advanced care-at-home strategies can be crucial during times of COVID-19 to minimize treatment interruptions and reduce the risk of cross-infections.
Keyphrases
- healthcare
- quality improvement
- end stage renal disease
- primary care
- palliative care
- sars cov
- coronavirus disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- emergency department
- pain management
- patient reported outcomes
- replacement therapy
- adverse drug
- electronic health record